These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 33359394)
21. Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway. Tang L; Mo Y; Li Y; Zhong Y; He S; Zhang Y; Tang Y; Fu S; Wang X; Chen A Biochem Biophys Res Commun; 2017 May; 486(3):774-780. PubMed ID: 28343995 [TBL] [Abstract][Full Text] [Related]
22. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway. Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089 [TBL] [Abstract][Full Text] [Related]
23. Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway. Wang HB; Duan MX; Xu M; Huang SH; Yang J; Yang J; Liu LB; Huang R; Wan CX; Ma ZG; Wu QQ; Tang QZ J Cell Mol Med; 2019 Aug; 23(8):5715-5727. PubMed ID: 31225721 [TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Fu J; Huang H; Liu J; Pi R; Chen J; Liu P Eur J Pharmacol; 2007 Jul; 568(1-3):213-21. PubMed ID: 17537428 [TBL] [Abstract][Full Text] [Related]
25. Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol. Lu F; Xing J; Zhang X; Dong S; Zhao Y; Wang L; Li H; Yang F; Xu C; Zhang W Mol Cell Biochem; 2013 Sep; 381(1-2):41-50. PubMed ID: 23660955 [TBL] [Abstract][Full Text] [Related]
26. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy. Miller CL; Oikawa M; Cai Y; Wojtovich AP; Nagel DJ; Xu X; Xu H; Florio V; Rybalkin SD; Beavo JA; Chen YF; Li JD; Blaxall BC; Abe J; Yan C Circ Res; 2009 Nov; 105(10):956-64. PubMed ID: 19797176 [TBL] [Abstract][Full Text] [Related]
27. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats. Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157 [TBL] [Abstract][Full Text] [Related]
28. Secretoneurin suppresses cardiac hypertrophy through suppression of oxidant stress. Chen HL; Liu Y; Jiang W; Wang XX; Yuan GL; Zhao YL; Yu C Eur J Pharmacol; 2018 Mar; 822():13-24. PubMed ID: 29337195 [TBL] [Abstract][Full Text] [Related]
29. Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B. Yang L; Zhang Y; Zhu M; Zhang Q; Wang X; Wang Y; Zhang J; Li J; Yang L; Liu J; Liu F; Yang Y; Kang L; Shen Y; Qi Z Free Radic Biol Med; 2016 Dec; 101():1-9. PubMed ID: 27667182 [TBL] [Abstract][Full Text] [Related]
30. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes. Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696 [TBL] [Abstract][Full Text] [Related]
32. Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo. Chen L; Liu P; Feng X; Ma C J Cell Mol Med; 2017 Dec; 21(12):3178-3189. PubMed ID: 28905500 [TBL] [Abstract][Full Text] [Related]
33. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway. Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642 [TBL] [Abstract][Full Text] [Related]
34. KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathways. Yeh JL; Hsu JH; Wu PJ; Liou SF; Liu CP; Chen IJ; Wu BN; Dai ZK; Wu JR Br J Pharmacol; 2010 Mar; 159(5):1151-60. PubMed ID: 20132211 [TBL] [Abstract][Full Text] [Related]
35. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways. Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558 [TBL] [Abstract][Full Text] [Related]
36. Pretreatment with β-glucan attenuates isoprenaline-induced myocardial injury in rats. Çetin E Exp Physiol; 2019 Apr; 104(4):505-513. PubMed ID: 30677174 [TBL] [Abstract][Full Text] [Related]
37. Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway. Li Y; He B; Zhang C; He Y; Xia T; Zeng C Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986070 [TBL] [Abstract][Full Text] [Related]
38. Globular adiponectin attenuates myocardial ischemia/reperfusion injury by upregulating endoplasmic reticulum Ca²⁺-ATPase activity and inhibiting endoplasmic reticulum stress. Guo J; Bian Y; Bai R; Li H; Fu M; Xiao C J Cardiovasc Pharmacol; 2013 Aug; 62(2):143-53. PubMed ID: 23609327 [TBL] [Abstract][Full Text] [Related]
39. Effects of taurine on myocardial cGMP/cAMP ratio, antioxidant ability, and ultrastructure in cardiac hypertrophy rats induced by isoproterenol. Yang Q; Yang J; Wu G; Feng Y; Lv Q; Lin S; Hu J Adv Exp Med Biol; 2013; 776():217-29. PubMed ID: 23392885 [TBL] [Abstract][Full Text] [Related]
40. Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models. Ozakca I J Cardiovasc Pharmacol; 2019 Mar; 73(3):155-164. PubMed ID: 30601193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]